Kian-Huat Lim, M.D., Ph.D.
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kian-Huat Lim, M.D., Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:45 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03883919 · Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based TherapyWashington University School of Medicine · completed · Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas
- Ph1/Ph2NCT03496662 · BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Washington University School of Medicine · completed · Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph2NCT03141034 · Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction AdenocarcinomaWashington University School of Medicine · completed · Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma · principal investigator
- Ph1NCT02608229 · BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic CancerWashington University School of Medicine · terminated · Pancreatic Cancer, Cancer of Pancreas, Cancer of the Pancreas · principal investigator
- Ph1NCT02546531 · Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced CancerWashington University School of Medicine · completed · Advanced Solid Tumors, Solid Tumors, Pancreatic Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccineP50CA196510 · NCI · WASHINGTON UNIVERSITY · PI William E. Gillanders · fiscal years 2016 to 2020Named on NCT03496662, NCT02608229
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.